First-cycle absolute neutrophil count can be used to improve chemotherapy-dose delivery and reduce the risk of febrile neutropenia in patients receiving adjuvant therapy: a validation study

BACKGROUND: The nadir value of the absolute neutrophil count (ANC) in the first cycle of chemotherapy is an effective predictor of subsequent neutropenic events. This study was designed to validate an earlier published study based on a retrospective data analysis from a prospective randomized clinic...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Rivera, Edgardo, Haim Erder, M, Fridman, Moshe, Frye, Debra, Hortobagyi, Gabriel N
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2003
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC314422/
https://ncbi.nlm.nih.gov/pubmed/12927041
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares